Remove Communication Remove Events Remove Immunization
article thumbnail

9 Pharmacy Advertising Ideas to Attract More Patients in 2024

Digital Pharmacist

Texting campaigns can be the most effective form of communicating messages to your patients if you use them correctly. Host Virtual Events From live videos and wellness classes to educational webinars and industry conferences, hosting a virtual event is a low-cost way to expand your online audience.

article thumbnail

Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication

Pharmaceutical Technology

According to the US-based company, the results demonstrate that Gritstone’s samRNA vaccine candidate boosted immunity for at least 6 months in previously vaccinated older adults. Most adverse events (AEs) following dosing were mild to moderate and transient with no treatment-related serious AEs observed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Enhancing collaboration to optimise medication therapy in older adults with cancer: a position paper from SOFOG-SFPO

Hospital Pharmacy Europe

There are often difficulties with adherence from multiple causes including communication difficulties, dysphagia, polypharmacy and adverse drug events. Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes. Crit Rev Oncol Hematol 2023;190:104117 de Jong MR, Van der Elst M, Hartholt KA.

article thumbnail

Sunshine Biopharma signs licence deal for Covid-19 treatment

Pharmaceutical Technology

PLpro is the second coronavirus protease responsible for suppressing the human immune system, causing more severe Covid-19. The company believes that a second protease inhibitor will help provide another target for combating the virus and mitigating the possible resistance events. Please check your email to download the Whitepaper.

article thumbnail

Reflecting on 2024: A Year of Progress in Advancing Quality

PQA

This fall, we launched a pilot to evaluate the effectiveness of pharmacies in improving adult immunization rates through VBAs with payers. Contact us at Communications@PQAalliance.org for questions about this program. Results from this two-year project will be shared in 2026.

article thumbnail

Sanofi’s frexalimab shows early potential in in Phase II multiple sclerosis trial

Pharmaceutical Technology

A large majority (97%) of patients completed part A of the trial, and frexalimab was generally well tolerated – adverse events were limited to a small number of Covid-19 cases and headaches, as per a 31 May release. Following these positive results, Sanofi plans to initiate further RMS trials next year.

article thumbnail

How to counsel your patients with long COVID

The Checkup by Singlecare

Cardiovascular events: Patients with pre-existing heart conditions may be at a higher risk of a heart attack or stroke after having COVID. Immune problems: Autoimmune conditions in which the immune system mistakenly attacks healthy cells can develop and lead to a range of autoimmune diseases.